79 results
6-K
EX-99.1
THTX
Theratechnologies Inc.
10 Apr 24
Interim Consolidated Financial Statements
8:30am
arrangements and warrant liabilities, which are measured at fair value. Equity-classified shared-based payment arrangements are measured at fair … warrant, a “Public Offering Warrant”) and is classified in Share Capital and Public Offering Warrants within equity. During the first quarter ended
6-K
EX-99.1
THTX
Theratechnologies Inc.
21 Feb 24
Theratechnologies Reports Financial Results
8:00am
activities, which were previously classified as cash flow from financing activities and interest received as cash flows from investing activities.
During
F-3
THTX
Theratechnologies Inc.
21 Dec 23
Shelf registration (foreign)
1:21pm
to Investissement Québec as part of the Concurrent Private Placement, as the Exchangeable Subscription Receipts are equity-classified.
The applicable … as at August 31, 2023, was classified as a current liability as at such date due to a breach of the Marathon Credit Agreement that was unwaived
6-K
EX-99.1
THTX
Theratechnologies Inc.
26 Oct 23
Current report (foreign)
9:15pm
of the Offered Shares and the nature of the Company’s business, the Company does not expect to be classified as a PFIC for the taxable year ending November 30 … to be classified as a CFC for the taxable year ending November 30, 2023.
(bbb) Choice of Law. The Company has the power to designate, appoint
SUPPL
pv54d
26 Oct 23
Supplemental materials (foreign)
9:13pm
SUPPL
osw5u qusd4z
25 Oct 23
Supplemental materials (foreign)
6:56pm
6-K
EX-99.1
bjq3lw0m92mj
26 Sep 23
Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates
8:02am
6-K
EX-99.1
6vp qzbm2u
26 Sep 23
Interim Consolidated Financial Statements
8:00am
6-K
EX-99.2
d4sev7r5vkcutc2anv
26 Sep 23
Interim Consolidated Financial Statements
8:00am
6-K
EX-99.1
jinibwklby5rz3sqn nq
12 Jul 23
Interim Consolidated Financial Statements
8:02am
6-K
EX-99.2
wqx7bx
12 Jul 23
Interim Consolidated Financial Statements
8:02am
6-K
EX-99.1
75rwlrl0vhwa04ri2wec
12 Jul 23
Theratechnologies Reports Second Quarter 2023
8:00am
6-K
EX-99.1
epl68vdx 1rfgs18
12 Apr 23
Interim Consolidated Financial Statements
8:00am
6-K
EX-99.2
dqomjt
12 Apr 23
Interim Consolidated Financial Statements
8:00am
6-K
EX-99.1
5ulld80mnu73xxju049
12 Apr 23
Theratechnologies Reports Financial Results and Business Updates for First Quarter 2023
7:45am
6-K
EX-99.1
6xz14
13 Oct 22
Interim Consolidated Financial Statements
8:01am
6-K
EX-99.2
tnb6u6vq
21 Jul 22
Material Change Report
4:40pm
6-K
EX-99.1
gk7pzpf1
14 Jul 22
Interim Consolidated Financial Statements
8:00am
6-K
EX-99.1
e6n553mq
13 Apr 22
Interim Consolidated Financial Statements
7:45am